Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Novel pandemic flu vaccine effective against H5N1 in mice

02.03.2009
Vaccines against H5N1 influenza will be critical in countering a possible future pandemic. Yet public health experts agree that the current method of growing seasonal influenza vaccines in chicken eggs is slow and inefficient.

Scientists at the Emory Vaccine Center have developed an alternative: virus-like particles, empty shells that look like viruses but don't replicate. Mice immunized by nose drops with the virus-like particles (VLPs) were protected for months against an otherwise lethal H5N1 infection.

The results are described in the March issue of PLoS ONE (Public Library of Science ONE).

"These results suggest that VLPs could form the basis of an effective human vaccine against H5N1 influenza," says senior author Richard Compans, PhD, professor of microbiology and immunology at Emory University School of Medicine.

Several worldwide influenza outbreaks have occurred during the past century, with the worst being the Spanish Flu of 1918, which killed more than 50 million people.

The H5N1 variant of influenza, found among birds in Asia in the 1990s, has killed the majority of the several hundred people known to have been infected with it. Public health officials fear that H5N1, to which the human population has not developed immunity, could evolve to be transmissible between humans and cause a global pandemic with very high mortality.

Making influenza vaccines in chicken eggs poses several disadvantages. Producing vaccines takes months. Making enough for millions of people could severely stress the world's vaccine-making capacity, especially since the poultry industry would probably be crippled in a pandemic. In addition, work with live H5N1 virus is dangerous and should only be performed in special laboratories.

As an alternative to live influenza viruses, VLPs are made by introducing three separate viral genes into baculoviruses, which only infect insect cells. Baculovirus-infected insect cells are then grown in culture, in a similar fashion to bacteria or yeast, and produce the VLPs. The VLPs appear to have a structure like influenza viruses under an electron microscope but lack the ability to replicate or to cause influenza.

Compans and first author Sang-Moo Kang, PhD, Emory assistant professor of microbiology and immunology, demonstrated the ability of VLPs to stimulate antibody production in mice. In collaboration with a team at the Centers for Disease Control and Prevention led by Ruben Donis, PhD, they showed that the mice immunized with VLPs could resist an otherwise lethal dose of H5N1 virus isolated from Vietnam.

The mice's immunity, including the levels of antibodies that protected their respiratory systems, stayed stable for over six months.

In mice, VLPs appear to deliver several times more potency per microgram than other types of vaccines, such as the chemically inactivated subunit viral vaccine currently used in the United States or a single viral protein produced in baculovirus.

"This extra potency is important because the current egg-grown vaccines require relatively high doses to be effective for most people, and in a pandemic demand might run up against production capacity. VLPs could offer more bang for the buck," Compans says.

Some next steps in the development of the vaccine are to find out if it can also protect against infection by mutant forms of the virus that arise frequently in birds, he says. Also, the vaccine will be evaluated in other animal species, in which influenza causes disease symptoms similar to those seen in humans.

Holly Korschun | EurekAlert!
Further information:
http://www.emory.edu
http://dx.plos.org/10.1371/journal.pone.0004667

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>